Literature DB >> 3759976

Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin.

M Yamagata, K M Yamada, M Yoneda, S Suzuki, K Kimata.   

Abstract

Preparations of cellular fibronectin from chick embryonic fibroblasts have previously been shown to have hyaluronate-binding activity. However, gel filtration and CsCl isopycnic centrifugation of fibronectin preparations showed that the binding activity was associated with molecules with a density and a molecular weight higher than those of fibronectin. An immunoprecipitation assay using antibodies to the chondroitin sulfate proteoglycan (PG-M) from the mesenchyme of chick embryo limb bud showed that the hyaluronate-binding activity of fibronectin preparations was precipitable with this antibody. The immunoprecipitation analyses also showed that fibronectin preparations as well as conditioned culture medium and extracts of chick embryonic fibroblasts contained a chondroitin sulfate proteoglycan, the protein-enriched core molecules from which were identical to those from PG-M with respect to electrophoretic mobility and immunological reactivity. This proteoglycan was purified from conditioned culture medium and extracts of fibroblasts by dissociative CsCl isopycnic centrifugation. The proteoglycans from medium or extracts gave core derivatives with electrophoretic mobility identical to those from PG-M, and they had equal hyaluronate-binding activities. These results, taken together, suggest that most, if not all, of the hyaluronate-binding activity in preparations of chick cellular fibronectin is due to a proteoglycan identical to PG-M. This proteoglycan was also found to bind directly to fibronectin and to type I collagen, but not to laminin or type IV collagen. It is possible that the fibroblast proteoglycan mediates interactions between hyaluronate, fibronectin, and type I collagen, thereby participating in formation of the pericellular matrix of fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

3.  Expression and localization of versican during postnatal development of rat temporomandibular joint disc.

Authors:  Naoko Toriya; Taishin Takuma; Toshiya Arakawa; Yoshihiro Abiko; Yasuyuki Sasano; Ichiro Takahashi; Yasunori Sakakura; Firoz Rahemtulla; Itaru Mizoguchi
Journal:  Histochem Cell Biol       Date:  2005-09-27       Impact factor: 4.304

4.  Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos.

Authors:  M Yamagata; T Shinomura; K Kimata
Journal:  Anat Embryol (Berl)       Date:  1993-05

5.  Versican G1 domain and V3 isoform overexpression results in increased chondrogenesis in the developing chick limb in ovo.

Authors:  Karla S Hudson; Kristen Andrews; June Early; Corey H Mjaatvedt; Anthony A Capehart
Journal:  Anat Rec (Hoboken)       Date:  2010-08-20       Impact factor: 2.064

Review 6.  Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity.

Authors:  Athanasios Papadas; Garrett Arauz; Alexander Cicala; Joshua Wiesner; Fotis Asimakopoulos
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

7.  Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.

Authors:  William Weidong Du; Burton B Yang; Tatiana A Shatseva; Bing L Yang; Zhaoqun Deng; Sze Wan Shan; Daniel Y Lee; Arun Seth; Albert J Yee
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

8.  Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

Authors:  John M Norian; Minnie Malik; Candace Y Parker; Doina Joseph; Phyllis C Leppert; James H Segars; William H Catherino
Journal:  Reprod Sci       Date:  2009-08-21       Impact factor: 3.060

9.  Long term effects of alumina on components of bronchoalveolar lavage fluid from rats.

Authors:  G Tornling; E Blaschke; A Eklund
Journal:  Br J Ind Med       Date:  1993-02

10.  Alteration of chondroitin sulfate composition on proteoglycan produced by knock-in mouse embryonic fibroblasts whose versican lacks the A subdomain.

Authors:  Keittisak Suwan; Sonoko Hatano; Prachya Kongtawelert; Peraphan Pothacharoen; Hideto Watanabe
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.